Senator Dick Durbin reintroduced the Dietary Supplement Listing Act of 2026 (S.3677) on January 15, 2026, per Congress.gov. The bill would amend the Federal Food, Drug, and Cosmetic Act so that every dietary supplement marketed in the United States must be listed with the FDA — basic product information filed for a new Section 403D, closing a gap that lets products reach shelves without the agency ever knowing they exist.
This site publishes information, not medical or legal advice, and takes no position on the legislation. The bill has only been introduced; it is referred to the Senate Committee on Health, Education, Labor, and Pensions and has not been voted on by either chamber.
What the bill would actually do
Under the proposed Section 403D, manufacturers, packers, and distributors would submit key product details to the FDA, including the product's name and the dietary ingredients it contains, per the bill text. The stated aim is transparency: today, under the 1994 law that governs supplements, the agency generally learns about a product only after it is already on the market.
The proposal is a reintroduction — Durbin has carried similar mandatory-listing bills in prior Congresses without them becoming law. This time the industry's own trade groups are split in tone: CRN, the supplement industry's largest trade association, published a critical response, while CHPA welcomed the reintroduction in a January 2026 statement.
Related stories: Lawmakers Take Another Run at Front-of-Package Food Labels · FDA Approves the First mRNA Seasonal Flu Vaccine.
What it changes for everyday exercisers
If you buy protein powder, creatine, or a multivitamin, nothing changes at the register today — and nothing would change quickly even if the bill passed, because it would take rulemaking and compliance timelines to take effect. The practical value is downstream. A public registry would let you check whether a product you take is actually known to the agency, the same way you can look up an approved drug today.
Until any such system exists, the boring safeguards still do the most work: choose products with third-party certification marks, buy from retailers with their own vetting programs, and treat "proprietary blend" labels with skepticism.
The point of context other coverage skipped
The FDA's supplement problem is mostly a visibility problem. The agency can act against adulterated or misbranded products, but it has to find them first — and its own statements about tainted products describe a market of tens of thousands of items with no complete list. That is why listing bills keep coming back: a registry would not ban anything by itself, but it converts an invisible market into a searchable one, which changes what enforcement, research, and recalls can even see. Coverage framed around "tougher regulation" missed that the core of S.3677 is information infrastructure, not restrictions.
Frequently asked questions
Has the Dietary Supplement Listing Act become law?
No. S.3677 was introduced on January 15, 2026 and referred to the Senate HELP committee, per Congress.gov. As of late February 2026 it had no floor vote, and companion House legislation was introduced by Rep. Dexter.
Would I need a prescription for supplements if it passes?
No. The bill requires manufacturers to list products with the FDA, per the bill text; it does not change supplements' status as a category you buy over the counter, and it does not make the FDA approve products before sale.